Birger Åstedt

7.3k total citations
232 papers, 5.8k citations indexed

About

Birger Åstedt is a scholar working on Hematology, Cancer Research and Biotechnology. According to data from OpenAlex, Birger Åstedt has authored 232 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Hematology, 82 papers in Cancer Research and 40 papers in Biotechnology. Recurrent topics in Birger Åstedt's work include Protease and Inhibitor Mechanisms (80 papers), Blood Coagulation and Thrombosis Mechanisms (79 papers) and Enzyme Production and Characterization (40 papers). Birger Åstedt is often cited by papers focused on Protease and Inhibitor Mechanisms (80 papers), Blood Coagulation and Thrombosis Mechanisms (79 papers) and Enzyme Production and Characterization (40 papers). Birger Åstedt collaborates with scholars based in Sweden, Denmark and Germany. Birger Åstedt's co-authors include Ingegerd Lecander, Lars Holmberg, Claes Lindoff, Bertil Casslén, L Svanberg, Inga Marie Nilsson, Percy Liedholm, Maurizio Pandolfi, Ulla Hedner and Satish Batra and has published in prestigious journals such as Nature, The Lancet and JAMA.

In The Last Decade

Birger Åstedt

228 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birger Åstedt Sweden 41 2.1k 1.9k 746 715 640 232 5.8k
A P Sappino Switzerland 23 927 0.4× 1.7k 0.9× 713 1.0× 1.4k 1.9× 86 0.1× 32 4.2k
Helena Autio‐Harmainen Finland 39 440 0.2× 1.1k 0.6× 642 0.9× 1.4k 1.9× 140 0.2× 119 4.3k
E J Manseau United States 29 279 0.1× 1.6k 0.8× 790 1.1× 3.9k 5.4× 203 0.3× 32 6.7k
Osamu Matsuo Japan 34 1.2k 0.5× 1.6k 0.9× 763 1.0× 1.4k 2.0× 25 0.0× 269 4.3k
Joaquín J. Jiménez United States 41 1.1k 0.5× 650 0.3× 516 0.7× 2.6k 3.6× 303 0.5× 154 6.0k
Elaine Unemori United States 37 342 0.2× 1.1k 0.6× 653 0.9× 1.1k 1.6× 191 0.3× 66 5.7k
Roeland Hanemaaijer Netherlands 49 680 0.3× 2.1k 1.1× 1.2k 1.6× 2.0k 2.8× 76 0.1× 104 6.4k
R Bach United States 33 2.4k 1.1× 337 0.2× 578 0.8× 864 1.2× 247 0.4× 64 4.2k
H. William Schnaper United States 42 340 0.2× 1.1k 0.6× 648 0.9× 3.1k 4.4× 155 0.2× 84 6.1k
Thomas T. Sato United States 30 778 0.4× 1.6k 0.9× 1.1k 1.4× 5.6k 7.8× 329 0.5× 89 9.4k

Countries citing papers authored by Birger Åstedt

Since Specialization
Citations

This map shows the geographic impact of Birger Åstedt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birger Åstedt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birger Åstedt more than expected).

Fields of papers citing papers by Birger Åstedt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birger Åstedt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birger Åstedt. The network helps show where Birger Åstedt may publish in the future.

Co-authorship network of co-authors of Birger Åstedt

This figure shows the co-authorship network connecting the top 25 collaborators of Birger Åstedt. A scholar is included among the top collaborators of Birger Åstedt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birger Åstedt. Birger Åstedt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Åstedt, Birger & Claes Lindoff. (1997). Plasminogen activators and plasminogen activator inhibitors in plasma of premature and term newborns. Acta Paediatrica. 86(1). 111–113. 3 indexed citations
4.
Lindoff, Claes, et al.. (1996). Transdermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease. Maturitas. 24(1-2). 43–50. 39 indexed citations
5.
Hartley‐Asp, Beryl, et al.. (1995). The urokinase inhibitor p‐aminobenzamidine inhibits growth of a human prostate tumor in scid mice. International Journal of Cancer. 61(4). 542–547. 28 indexed citations
6.
Casslén, Bertil, et al.. (1991). Cell membrane receptors for urokinase plasminogen activator are increased in malignant ovarian tumours. European Journal of Cancer and Clinical Oncology. 27(11). 1445–1448. 52 indexed citations
7.
Jensen, Poul Henning, Anders Nykjær, Peter A. Andreasen, et al.. (1989). Urokinase binds to a plasminogen activator inhibitor type-2-like molecule in placental microvillous membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 986(1). 135–140. 18 indexed citations
8.
Jonasson, Aino Fianu, B. Larsson, Ingegerd Lecander, & Birger Åstedt. (1989). The effect of cervical dilatation by laminaria tent in first trimester legal abortions on blood loss related to fibrinolytic activity in the decidua and placenta. International Journal of Gynecology & Obstetrics. 29(1). 73–77. 6 indexed citations
9.
Kjældgaard, Anders, et al.. (1988). Progestogen regulation of tissue plasminogen activator in a human melanoma cell line. Thrombosis Research. 49(2). 287–297. 18 indexed citations
10.
Hibino, Toshihiko, et al.. (1988). Epidermal plasminogen activator inhibitor (PAI) is immunologically identical to placental‐type PAI‐2. FEBS Letters. 231(1). 202–206. 33 indexed citations
11.
Åstedt, Birger. (1987). Cancer and Other Risk Factors with Estrogen Replacement. Acta Obstetricia Et Gynecologica Scandinavica. 66(S140). 46–51. 3 indexed citations
12.
Åstedt, Birger, W. Mattsson, & Claes G. Tropé. (1977). Treatment of Advanced Breast Cancer with Chemotherapeutics and Inhibition of Coagulation and Fibrinolysis. Acta Medica Scandinavica. 201(1-6). 491–493. 28 indexed citations
13.
Larsson, B., Percy Liedholm, & Birger Åstedt. (1975). Effect of copper and plastic intra-uterine devices on the fibrinolytic activity of the endometrium in the rat.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 20(3). 145–50. 17 indexed citations
14.
Liedholm, Percy & Birger Åstedt. (1975). Fibrinolytic activity of the rat ovum, appearance during tubal passage and disappearance at implantation.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 20(1). 24–6. 27 indexed citations
15.
Larsson, Britt, Percy Liedholm, & Birger Åstedt. (1975). Increased fibrinolytic activity in the endometrium of patients using copper-iud (gravigard).. VocBench (University of Rome Tor Vergata). 20(2). 77–80. 27 indexed citations
16.
Åstedt, Birger. (1975). Fibrinolysis in Cultured Cells. Thrombosis and Haemostasis. 34(3). 644–647. 2 indexed citations
17.
Holmberg, Lars, P. Henriksson, H. EKELUND, & Birger Åstedt. (1974). Coagulation in the human fetus. The Journal of Pediatrics. 85(6). 860–864. 49 indexed citations
18.
Liedholm, Percy, Birger Åstedt, & Stig Kullander. (1973). Passage of Tranexamic Acid (AMCA) to Semen in Man and its Effect on the Fibrinolytic Activity and on Migration of Spermatozoa. Fertility and Sterility. 24(7). 517–520. 17 indexed citations
19.
Arvidson, Gösta, H. EKELUND, & Birger Åstedt. (1972). Phospholipid Composition of Human Amniotic Fluid During Gestation and at Term. Acta Obstetricia Et Gynecologica Scandinavica. 51(1). 71–75. 28 indexed citations
20.
Nilsson, I.M. & Birger Åstedt. (1971). Blood clotting and contraception.. BMJ. 2(5761). 589.3–590. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A P Sappino Breakdown of academic impact, for papers by Helena Autio‐Harmainen Breakdown of academic impact, for papers by E J Manseau Breakdown of academic impact, for papers by Osamu Matsuo Breakdown of academic impact, for papers by Joaquín J. Jiménez Breakdown of academic impact, for papers by Elaine Unemori Breakdown of academic impact, for papers by Roeland Hanemaaijer Breakdown of academic impact, for papers by R Bach Breakdown of academic impact, for papers by H. William Schnaper Breakdown of academic impact, for papers by Thomas T. Sato
Rankless by CCL
2026